India’s Sun Pharmaceutical Industries agrees to buy the women’s health company for $14 a share in an all-cash deal.

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc. (NASDAQ:BIIB) was ...

Well, I read the upgrade today by Wells Fargo, and it talked about a bunch of revenue streams. including Alzheimer’s, and it ...

Biogen (NASDAQ:BIIB) picked up a strong endorsement from Wall Street on Wednesday, as UBS analyst Michael Yee upgraded the ...

Biogen Inc. (NASDAQ: BIIB) has recently been upgraded to a “Buy” rating by UBS analyst Michael Yee, with a new price target set at $225, signaling strong upside potential from the current trading ...

Futures are trading higher as we hit the midweek point. All major indices finished lower on Tuesday as the deadline for the ...

The investment bank upgraded the pharmaceutical name to buy from neutral. It also hiked its price target on shares to $225 ...

Biogen Inc. has consolidated full global rights to felzartamab through an $850 million deal with TJ Biopharma Co. Ltd. April ...

Agilent's Technologies' Joydeep Ganguly brought a surgeon's precision to LogiPharma Vienna and a radical vision for the ...

AES, InterDigital, Infleqtion, Netskope, and Biogen. Got a confidential news tip? We want to hear from you. Sign up for free ...

With a market cap of $26 billion, Biogen Inc. (BIIB) is a global biotechnology company that discovers, develops, and delivers ...